EP Patent

EP0312000A1 — Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents

Assigned to Bristol Myers Squibb Pharma Co · Expires 1989-04-19 · 37y expired

What this patent protects

Aminomethyl oxooxazolidinyl aroylbenzene derivatives, such as ℓ-N-(3-[4-(2,4-difluorobenzoyl)phenyl]-2- oxooxazolidin-5-ylmethyl]acetamide, possess useful antibacterial activity.

USPTO Abstract

Aminomethyl oxooxazolidinyl aroylbenzene derivatives, such as ℓ-N-(3-[4-(2,4-difluorobenzoyl)phenyl]-2- oxooxazolidin-5-ylmethyl]acetamide, possess useful antibacterial activity.

Drugs covered by this patent

tedizolid-phosphate (TEDIZOLID PHOSPHATE)

Patent Metadata

Patent number: EP0312000A1
Jurisdiction: EP
Classification: —
Expires: 1989-04-19
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Pharma Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.